Alpha Tau Medical Ltd.DRTSNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank85
5Y CAGR-24.3%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-24.3%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 18.47% |
| Q2 2025 | -2.20% |
| Q1 2025 | -4.82% |
| Q4 2024 | 22.03% |
| Q3 2024 | -10.09% |
| Q2 2024 | 6.48% |
| Q1 2024 | -13.91% |
| Q4 2023 | 12.24% |
| Q3 2023 | 12.06% |
| Q2 2023 | -5.57% |
| Q1 2023 | 17.21% |
| Q4 2022 | 11.46% |
| Q3 2022 | -11.40% |
| Q2 2022 | 4.07% |
| Q1 2022 | 62.12% |
| Q4 2021 | 6.50% |
| Q3 2021 | 1.17% |
| Q2 2021 | 36.91% |
| Q1 2021 | -18.23% |
| Q4 2020 | 0.00% |
| Q3 2020 | 74.51% |
| Q2 2020 | 0.00% |
| Q1 2020 | -7.53% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |